GLICLAZ -M is an oral anti-diabetic medication that combines two effective agents: Gliclazide, a sulfonylurea, and Metformin, a biguanide. This combination is used to manage Type 2 Diabetes Mellitus, especially in patients whose blood sugar levels are not adequately controlled through diet and exercise alone. Gliclazide works by stimulating the pancreas to release more insulin, thereby reducing blood sugar levels. Metformin, on the other hand, improves the body’s sensitivity to insulin and decreases glucose production in the liver. Together, they provide better glycemic control and reduce the risk of long-term diabetic complications.